68.19
-0.05
(-0.07%)
As of 9:38:38 AM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
290,403,000
290,403,000
232,261,000
176,954,000
140,800,000
Cost of Revenue
44,522,000
44,522,000
35,765,000
28,448,000
23,658,000
Gross Profit
245,881,000
245,881,000
196,496,000
148,506,000
117,142,000
Operating Expense
117,542,000
117,542,000
93,922,000
73,697,000
58,498,000
Operating Income
128,339,000
128,339,000
102,574,000
74,809,000
58,644,000
Net Non Operating Interest Income Expense
-91,000
-91,000
330,000
-320,000
-180,000
Other Income Expense
-1,057,000
-1,057,000
1,770,000
-5,427,000
616,000
Pretax Income
127,191,000
127,191,000
104,674,000
69,062,000
59,080,000
Tax Provision
26,203,000
26,203,000
20,991,000
13,537,000
11,323,000
Net Income Common Stockholders
100,988,000
100,988,000
83,683,000
55,525,000
47,757,000
Diluted NI Available to Com Stockholders
100,988,000
100,988,000
83,683,000
55,525,000
47,757,000
Basic EPS
21.25
22.67
18.67
12.26
10.39
Diluted EPS
21.20
22.63
18.62
12.22
10.37
Basic Average Shares
4,457,865.08
4,453,900
4,482,800
4,530,600
4,594,227.99
Diluted Average Shares
4,468,248.22
4,463,000
4,494,800
4,544,600
4,605,303.76
Total Operating Income as Reported
128,339,000
128,339,000
102,574,000
74,809,000
58,644,000
Total Expenses
162,064,000
162,064,000
129,687,000
102,145,000
82,156,000
Net Income from Continuing & Discontinued Operation
100,988,000
100,988,000
83,683,000
55,525,000
47,757,000
Normalized Income
101,813,760
101,813,760
82,333,489
59,736,352
47,239,880
Interest Income
1,838,000
1,838,000
1,069,000
239,000
231,000
Interest Expense
1,640,000
1,640,000
542,000
378,000
289,000
Net Interest Income
-91,000
-91,000
330,000
-320,000
-180,000
EBIT
128,831,000
128,831,000
105,216,000
69,440,000
59,369,000
EBITDA
137,376,000
137,376,000
114,629,000
76,802,000
65,394,000
Reconciled Cost of Revenue
44,522,000
44,522,000
35,765,000
28,448,000
23,658,000
Reconciled Depreciation
8,545,000
8,545,000
9,413,000
7,362,000
6,025,000
Net Income from Continuing Operation Net Minority Interest
100,988,000
100,988,000
83,683,000
55,525,000
47,757,000
Total Unusual Items Excluding Goodwill
-1,040,000
-1,040,000
1,689,000
-5,238,000
640,000
Total Unusual Items
-1,040,000
-1,040,000
1,689,000
-5,238,000
640,000
Normalized EBITDA
138,416,000
138,416,000
112,940,000
82,040,000
64,754,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-214,240
-214,240
339,489
-1,026,648
122,880
12/31/2021 - 4/30/1981
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LLY Eli Lilly and Company
814.25
-0.49%
JNJ Johnson & Johnson
158.70
+2.15%
PFE Pfizer Inc.
24.66
-0.16%
MRK Merck & Co., Inc.
87.84
+1.43%
ABBV AbbVie Inc.
209.50
+2.10%
BMY Bristol-Myers Squibb Company
60.21
+1.03%
AMGN Amgen Inc.
311.77
+1.99%
AZN AstraZeneca PLC
75.41
+4.42%
GILD Gilead Sciences, Inc.
114.03
+1.91%
BIIB Biogen Inc.
131.81
+0.37%